Document is current
Any future updates will be listed below
-
Authors
Kimmel, Blaise R. https://orcid.org/0000-0002-9582-9887
Arora, Karan https://orcid.org/0000-0003-1472-1637
Chada, Neil C. https://orcid.org/0000-0003-4566-3564
Bharti, Vijaya
Kwiatkowski, Alexander J. https://orcid.org/0000-0001-5435-3555
Finkelstein, Jonah E.
Hanna, Ann
Arner, Emily N. https://orcid.org/0000-0003-3589-8829
Sheehy, Taylor L. https://orcid.org/0000-0002-3100-8115
Pastora, Lucinda E.
Yang, Jinming
Pagendarm, Hayden M. https://orcid.org/0000-0001-7611-6120
Stone, Payton T. https://orcid.org/0000-0002-8105-0610
Hargrove-Wiley, Ebony https://orcid.org/0000-0003-4452-4917
Taylor, Brandie C. https://orcid.org/0000-0002-4862-4678
Hubert, Lauren A.
Fingleton, Barbara M.
Gibson-Corley, Katherine N. https://orcid.org/0000-0002-1846-1580
May, Jody C. https://orcid.org/0000-0003-4871-5024
McLean, John A. https://orcid.org/0000-0001-8918-6419
Rathmell, Jeffrey C. https://orcid.org/0000-0002-4106-3396
Richmond, Ann https://orcid.org/0000-0002-9580-900X
Rathmell, W. Kimryn https://orcid.org/0000-0002-4984-0225
Balko, Justin M. https://orcid.org/0000-0002-4263-5974
Wilson, John T. https://orcid.org/0000-0002-9144-2634
-
Funding
Funding for this research was provided by:
Susan G. Komen (CCR19609205)
U.S. Department of Health & Human Services | NIH | National Cancer Institute (R01 CA245134, R01 CA266767, R01 CA274675, P30 CA68485, T32CA009592, F32 CA288044, K00 CA253718, T32CA009592, R01 CA217987, R01 CA11601, SPORE 2P50CA098131–17)
National Science Foundation (CBET-1554623, 193793, 193793, 193793, 193793, DMR 1852157)
Pharmaceutical Research and Manufacturers of America Foundation (Postdoctoral Fellowship in Drug Delivery)
U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (T32GM007347, T32GM065086)
U.S. Department of Health & Human Services | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (T32DK101003, T32DK101003)
U.S. Department of Veterans Affairs (IK6B005225)
United States Department of Defense | United States Army | Army Medical Command | Congressionally Directed Medical Research Programs (BC170037)
- License Information
-
More Information
Article History
Received: 7 August 2023
Accepted: 7 March 2025
First Online: 11 June 2025
Competing interests
: J.T.W., K.A. and B.R.K. are inventors on United States Patent Application PCT/US2023/079884 ‘NANOBODY-DRUG CONJUGATES AND METHODS OF PREPARING THEREOF’ which describes nanobody conjugation and delivery technologies. J.T.W. has received research support from Incyte Corporation within the past 3 years. J.C.R. is an employee of Vanderbilt University Medical Center and appointed to the Vanderbilt University School of Medicine. He is a scientific advisory board member of Sitryx Therapeutics. J.C.M. and J.A.M. received support from Agilent Technologies in the form of a Thought Leader Award. Agilent is a commercial manufacturer of the MS instrumentation used in aspects of this work. J.A.M. is a member of the Scientific Advisory Board for MOBILion Systems, which is a manufacturer of high-resolution ion mobility–MS instrumentation. J.A.M. certifies that his contributions are scientifically objective and not influenced by his Scientific Advisory Board participation. J.M.B. receives research support from Genentech/Roche and Incyte Corporation, has received advisory board payments from AstraZeneca, Eli Lilly and Mallinckrodt and is an inventor on patents regarding immunotherapy targets and biomarkers in cancer.
